Astounding HealthTech
Translating Tech For R&D-Driven Biopharmas
Advisory Services
Astounding provides advisory services to R&D-driven biopharma organizations and health tech startups striving to engage each other more effectively.
The mission of Astounding is to catalyze drug development by aligning the specific capabilities and distinct needs of individual health technology startups and R&D-driven biopharmaceutical companies to elicit the best of both.
Emerging health tech opportunities are:
- Increasingly abundant and compelling;
- Intriguing but largely peripheral to R&D today;
- Going to be core to R&D in the near future.
Transformative technology tends not to transform immediately or evenly; it takes time to figure out how to leverage new technology, and deep domain expertise to determine where specifically to aim it. Astounding seeks to address the emerging need for pragmatic insight informed by fluency with emerging technologies and experience making medicines, and guide health tech startups and R&D-driven biopharmaceutical companies through this period of profound uncertainty and enormous change, and collaboratively reimagine the future of drug development.
David A. Shaywitz, MD, PhD
Contact: DS {at} AstoundingHealthTech {dot} com